Pharmaceutical company Ferrer, a member of CataloniaBio & HealthTech, announces its continued commitment to digital health with the third edition of its innovation programme Ferrer 4 Future.

Ferrer 4 Future aims to empower entrepreneurs to co-develop disruptive health solutions using digital technology. Start-ups interested in participating in this edition must propose solutions to one of these challenges:

• Is there a digital solution that may help screen people with mild cognitive impairment and distinguish if there is a pathological evolution in cognitive functions, to allow long-term monitoring of the disease and provide the appropriate treatment?
  
  
• Is there an easy to use digital solution to maximise independence in the daily tasks of patients living with mild cognitive impairment, through personalized cognitive or motor rehabilitation?

Programme benefits for the winner are mentorship and training, partnership, access to resources and investment. 

Programme at a glance:

• 29 September, 2021: Application deadline.
• July-September 2021: If shortlisted, participants will deliver initial pitch.
• October-November 2021: If successful, participants are given the chance to present to expert panel, lasting one hour.
• Early 2022: Programme initiation.

In 2020, the winning start-up was Wellthy Therapeutics (India) and in 2019, Portabiles Healthcare Technologies (Germany). 

Photo: Gemma Estrada, director of Digital Health at Ferrer, presented the programme at 4YFN-Mobile World Congress Barcelona.